World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02790827
Date of registration: 24/05/2016
Prospective Registration: No
Primary sponsor: Johns Hopkins Bloomberg School of Public Health
Public title: Trial of a Multi-pronged Intervention to Address Prevention of Violence in Zambia
Scientific title: Randomized Controlled Trial of a Multi-pronged Intervention to Address Prevention of Violence in Zambia
Date of first enrolment: May 2016
Target sample size: 626
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02790827
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Zambia
Contacts
Name:     Laura Murray, PhD
Address: 
Telephone:
Email:
Affiliation:  Johns Hopkins Bloomberg School of Public Health
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Families living in the study compounds in Lusaka (i.e., not staying temporarily)

2. Speaking one of the three study languages: English, Bemba, or Nyanja

3. Having at least one male adult and one female adult 18 years of age or older and in a
relationship (married or dating) and one child between the ages of 8 to 17 identified
by the mother as the most affected by the violence (if multiple children in the home).
Child participation is optional.

4. The man and woman must both provide consent. If the female agree to have the child
participate and the child wants to participate, then parental permission and child
assent will be required.

5. The adult female must indicate during the inclusion screening at least a moderate
amount of violence within the family as measured by scoring a 38 or more on the
Severity of Violence Against Women Scale (SVAWS).

6. The male in the family must indicate that he drinks alcohol at hazardous levels or the
female must report that the male drinks alcohol at hazardous levels as evidenced by
scoring an 8 or higher on the Alcohol Use Disorders Identification Test (AUDIT).

Exclusion Criteria:

1. Any of the family members is currently on an unstable psychiatric drug regimen (i.e.,
regimen altered in last 2 months)

2. Any of the family members has had a suicide attempt or suicidal ideation with intent
or plan, or self-harm in the past month.

3. Any of the family members has been diagnosed with a current psychotic disorder
(identified by the University Teaching Hospital Psychiatric Unit).

4. Any of the family members has a serious developmental disorder (e.g., mental
retardation, autism) that would preclude participation in cognitive-behavioral
oriented skills intervention



Age minimum: 8 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Mental Health Impairment
Alcoholism
Child Abuse
Domestic Violence
Intervention(s)
Behavioral: Treatment as usual
Behavioral: CETA
Primary Outcome(s)
Change in violence against women as measured by Severity of Violence Against Women Scale (SVAWS) [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Secondary Outcome(s)
Change in alcohol abuse as measured by the Alcohol Use Disorders Identification Test (AUDIT) [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in psychological violence as measured by Index of Psychological Abuse [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in PTSD symptoms (adult) as measured by the Harvard Trauma Questionnaire (HTQ) [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in belief about gender norms as measured by the Gender Equitable Mens Scale (GEMS) [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in chronic stress as measured by hair cortisol [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in substance use as measured by the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in PTSD symptoms (child) as measured by the Child PTSD Symptom Scale (CPSS) [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in child aggression as measured by the Child Aggression Scale [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in child abuse as measured by the Youth Victimization Scale [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in child internalizing and externalizing symptoms as measured by the Youth Self Report (YSR) [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Change in depression symptoms as measured by the Center for Epidemiological Studies Depression Scale (CES-D) [Time Frame: Baseline, 4-5 months post-baseline, 12 months post-baseline, 24 months post-baseline]
Secondary ID(s)
IRB00006534
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
SHARPZ (Serenity Harm Reduction Programme Zambia)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history